A vaccine with University of Washington roots that fights a suite of coronaviruses including COVID-19 and related, deadly diseases is starting human clinical testing.
Ongoing federal support for mRNA technology and research could make good on a longstanding presidential promise to cure cancer, according to Jeff Coller, Bloomberg Distinguished Professor of RNA ...
A Moderna spokesperson said the company is aware of the lawsuit and will defend itself. Spokespeople for Pfizer, BioNTech and Johnson & Johnson did not immediately respond to requests for comment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results